NM Coordinating Committee: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ :Chairs: Richard Wahl, MD (Co-chair), Eric Perlman, MD (Co-chair), P. David Mozley, MD (Vice-chair) :Secretary: Susan Weinmann (RSNA Staff) :Roster: ''<link to roste..." |
mNo edit summary |
||
| (24 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD | |||
:Roster | *[https://tinyurl.com/QIBA-NM-CC-Roster '''Roster'''] | ||
==Scope== | ==Scope== | ||
The NM Coordinating Committee | The NM Coordinating Committee is responsible for: | ||
:* Monitoring and coordinating the activities of NM Biomarker Committees | |||
::* [https://docs.google.com/spreadsheets/d/1A7_uieyw0uu2DKbP6Vkzd37JuBEb2zmm-yqfXJtV-p4/edit?usp=sharing QIBA Profile Dashboard] (NM Page) | |||
:* Considering and proposing new candidate Biomarker Committees to the [[Steering Committee]] | :* Considering and proposing new candidate Biomarker Committees to the [[Steering Committee]] | ||
:* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee | :* Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee | ||
:* Approving for publication Biomarker Profiles developed by the NM Biomarker Committees | :* Approving for publication Biomarker Profiles developed by the NM Biomarker Committees | ||
::* [[FDG-PET_Biomarker_Ctte]] | ::*[[FDG-PET_Biomarker_Ctte]] | ||
::* [[PET_Amyloid_Biomarker_Ctte]] | ::* [[PET_Amyloid_Biomarker_Ctte]] | ||
::* [[SPECT_Biomarker_Ctte]] | ::* [[SPECT_Biomarker_Ctte]] | ||
::* TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee] | |||
::* I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee] | |||
::* PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee] | |||
* | |||
Latest revision as of 17:07, 17 January 2024
Co-Chairs: Robert deKemp, PhD; Nathan Christopher Hall, MD, PhD; Anne Smith, PhD
Scope
The NM Coordinating Committee is responsible for:
- Monitoring and coordinating the activities of NM Biomarker Committees
- QIBA Profile Dashboard (NM Page)
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
- FDG-PET_Biomarker_Ctte
- PET_Amyloid_Biomarker_Ctte
- SPECT_Biomarker_Ctte
- TC99m Biomarker Committee [page: https://qibawiki.rsna.org/index.php/TC99m_Biomarker_Committee]
- I-123 Biomarker Committee [page: https://qibawiki.rsna.org/index.php/I-123_Biomarker_Committee]
- PET Myocardial Blood Flow [page: https://qibawiki.rsna.org/index.php/PET_Myocardial_Blood_Flow_Biomarker_Committee]